[1]
“COMBINED MODALITY TREATMENT INCLUDING METHOTREXATE-BASED CHEMOTHERAPY FOR PRIMARY CEREBRAL NERVOUS SYSTEM LYMPHOMA: A SINGLE INSTITUTION EXPERIENCE”, Mediterr J Hematol Infect Dis, vol. 1, no. 2, p. e2009020, Dec. 2009, doi: 10.4084/mjhid.2009.020.